40:49
Ionis CEO: $3B Tryngolza Opportunity and the Next Wave of RNA Drugs
Ionis Mp3 & Mp4
40:49
09:08
Ionis Pharmaceuticals founder Stanley Crooke on the fight against rare diseases
06:55
Ionis Pharmaceuticals CEO: Our New Name | Mad Money | CNBC
17:28
Ionis Pharmaceuticals (IONS) Deep Dive: RNA Therapies, Breakthroughs & Stock Insights
10:35
Ionic Digital Is Going Public: How To Prepare To Sell Your Shares
06:33
Ionis Pharmaceuticals CEO Brett Monia on the drugs they are focused on
08:07
Ionis Pharmaceuticals CEO: High-Profile Partners | Mad Money | CNBC
03:21
Why Ionis
16:06
Arrowhead vs Alnylam vs Ionis: RNA Therapeutics Showdown (2025 Analysis)
07:27
Ionis Pharmaceuticals CEO: Healthy Returns | Mad Money | CNBC